Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZIOPHARM Oncology

0.8657
0.0000
Volume:- -
Turnover:1.91M
Market Cap:185.81M
PE:-2.06
High:0.8657
Open:0.8657
Low:0.8657
Close:0.8657
Loading ...

Here's Why Ziopharm Oncology Stock Is Up 18% This Week

Motley Fool
·
10 Sep 2021

Is the Options Market Predicting a Spike ZIOPHARM (ZIOP) Stock?

Zacks
·
08 Sep 2021

3 Penny Stocks Insiders Are Buying

Benzinga
·
07 Sep 2021

Ziopharm Oncology to Participate in September Investor Conferences

GlobeNewswire
·
02 Sep 2021

Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions

GlobeNewswire
·
30 Aug 2021

Ziopharm Oncology downgraded to market perform from outperform at Raymond James

Dow Jones
·
10 Aug 2021

Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

GlobeNewswire
·
27 Jul 2021

We Think ZIOPHARM Oncology (NASDAQ:ZIOP) Needs To Drive Business Growth Carefully

Simply Wall St.
·
22 Jun 2021

Ziopharm Oncology to Participate in Upcoming Conferences

GlobeNewswire
·
25 May 2021

Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting

GlobeNewswire
·
20 May 2021

ZIOPHARM Oncology Q1 EPS $(0.10), Inline

Benzinga
·
07 May 2021

Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21 Two-Day Live Virtual Educational Symposium

GlobeNewswire
·
04 May 2021

Ziopharm Oncology Scientific Advisor Laurence J. N. Cooper, PhD, MD, Presented Today at Aldevron’s Virtual Breakthrough Speakers Series

GlobeNewswire
·
29 Apr 2021

BRIEF-Ziopharm Oncology Reports First Patient Infused In CD19 RPM CAR-T Phase I Trial

Reuters
·
19 Apr 2021

Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell

GlobeNewswire
·
19 Apr 2021

Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting

GlobeNewswire
·
07 Apr 2021

What Type Of Shareholders Make Up ZIOPHARM Oncology, Inc.'s (NASDAQ:ZIOP) Share Registry?

Simply Wall St.
·
23 Mar 2021

BRIEF-Ziopharm Oncology Reports Q4 And Full Year 2020 Financial Results

Reuters
·
26 Feb 2021

ZIOPHARM Oncology Q4 EPS $(0.11) Misses $(0.10) Estimate

Benzinga
·
26 Feb 2021